Efficacy and safety of AYUSH SR in the management of Premenstrual Syndrome a Randomized Double Blind Placebo Controlled Study - Nil

Central Council For Research In Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1.Female participants of reproductive age group (18-40) with regular menstrual cycle (between 21 and 35 days) having moderate symptoms as per PSST tool(Premenstrual Symptoms Screening Tool).
•2.Symptoms should occur during the luteal phase.
•3.Willing to participate in the study

•1.Patients diagnosed with Uterine fibroids , polyps and congenital uterine anomalies.
•2.Diagnosed patients with diabetes mellitus, poorly controlled Hypertension(Blood pressure more than 160/100 mm of Hg) or hormonal disorders.
•3.Patients with concurrent hepatic disorderdefined as aspartate amino transferase and/or alanine amino transferase greater than 2 times the upper normal limit or renal disorders defined as serum Creatinine greater than the upper limit of laboratory value)
•4.Patients who are undergoing any hormonal treatment or using contraceptive pills.
•5.Psychiatric disorders and malignant conditions
•6.Pregnant/lactating females.
•7.Patients who have completed participation in any other clinical trial during the past six (06) months.
•8.Any other condition that the Investigator thinks may jeopardize the study

发起方